Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Giménez, F. Martinón, E. Bernaola, M. Baca, F. De Juan, J. Díez, et al.
El papel de la vacuna frente a rotavirus en los calendarios de vacunación infantil.
An Pediatr (Barc), 64 (2006), pp. 573-577
[2.]
F.R. Velázquez, D.O. Matson, J.J. Calva, L. Guerrero, A.L. Morrow, S. Carte-Campbell, et al.
Rotavirus infection in infants as protection against subsequent infections.
N Engl J Med., 335 (1996), pp. 1022-1028
[3.]
T. Vesikari, D.O. Matson, P. Dennehy, P. Van Damme, M. Santosham, Z. Rodríguez, et al.
Safety and Efficacy of a Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine.
N Engl J Med., 354 (2006), pp. 23-33
[4.]
R. Glass, U. Parashar, J. Bresse, R. Turcios, T.K. Fischer, M.A. Widdowson, et al.
Rotavirus vaccines: Current prospects and future challenges.
Lancet, 368 (2006), pp. 323-332
[5.]
Vesikari T. The efficacy of a pentavalent rotavirus vaccine on urgent care outcomes from 11 countries. 12th International Congress on Infectious Diseases; 2006 June 15-18; Lisbon.
[6.]
Y. Hoshino, L. Saif, S.Y. Kang, M.M. Sereno, W.K. Chen, A. Kapikian.
Identification of a Group A Rotaviruses Genes Associated with Virulence of a Porcine Rotavirus and Host Range Restriction of a Human Rotavirus in the Gnotobiotic Piglet Model.
Virology, 209 (1995), pp. 274-280
[7.]
Ficha técnica de Rotateq®. Disponible en: http://www.emea.europa.eu/humandocs/PDFs/EPAR/Rotateq/H-669-PI-es.pdf
Copyright © 2007. Asociación Española de Pediatría
